Compare CVU & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVU | XTNT |
|---|---|---|
| Founded | 1980 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.6M | 39.6M |
| IPO Year | 1996 | 2009 |
| Metric | CVU | XTNT |
|---|---|---|
| Price | $4.21 | $0.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $1.03 |
| AVG Volume (30 Days) | 56.0K | ★ 151.7K |
| Earning Date | 11-16-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.00 |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $69,262,124.00 | $53,337,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.85 |
| P/E Ratio | $30.07 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.29 | $0.26 |
| 52 Week High | $5.98 | $0.84 |
| Indicator | CVU | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 31.39 | 22.37 |
| Support Level | $3.60 | N/A |
| Resistance Level | $5.30 | $0.47 |
| Average True Range (ATR) | 0.25 | 0.03 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 4.72 | 21.87 |
CPI Aerostructures Inc is engaged in the manufacturing of structural aircraft parts for fixed-wing aircraft and helicopters in both the commercial and defense markets in the United States. It also provides engineering, program management, supply chain management and kitting, and Maintenance Repair and Overhaul (MRO) services. CPI also acts as a subcontractor to prime aircraft manufacturers in the production of commercial aircraft parts. CPI Aero supplies the E-2D Advanced Hawkeye surveillance aircraft, the A-10 Thunderbolt attack jet, the Gulfstream G650, the UH-60 BLACK HAWK helicopter, and the S-92 helicopter, and others.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.